- Conditions
- Postoperative Kidney Injury
- Interventions
- human albumin 5%, HES 130/0.4 (Voluven)
- Drug
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 40 Years to 85 Years
- Enrollment
- 149 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2020
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
Source: ClinicalTrials.gov public record
Updated Feb 13, 2023 · Synced May 22, 2026, 4:46 AM EDT